# 120/80 GROUP

> 120/80 GROUP is a privately held New York marketing and communications consultancy focused on healthcare, life sciences and the increasingly important overlap between health and artificial intelligence. Founded in 2018 as 120/80 MKTG by Rob Cronin and Jen Long, it now operates two agencies - the digital-health-focused 120/80 MKTG and AI-and-health consultancy AOx3 - supported by specialist units for content, corporate communications, research and growth marketing.

- **Founded:** 2018
- **Headquarters:** New York, United States
- **Founders:** Rob Cronin (Founder & CEO), Jen Long (Co-founder, 120/80 MKTG; Managing Partner & Chief Client Officer)
- **Products:** 120/80 MKTG, AOx3, 120/80 STUDIOS, 120/80 CORPORATE, 120/80 INSIGHTS
- **Notable:** Built 120/80 MKTG from a 2018 launch into a multi-brand group serving digital health, healthcare AI and life sciences., Created AOx3 in 2024 as a second consultancy focused on the use of technology and AI in health., Established shared centers for studios, corporate communications, insights and growth marketing.

## Products & services

- **120/80 MKTG** — The original digital-health consultancy, providing strategy, messaging, media relations, financial communications, analyst and influencer relations, social media, events and measurement.
- **AOx3** — A consultancy for organizations applying technology and artificial intelligence to health and life sciences, based in Silicon Valley and New York.
- **120/80 STUDIOS** — Content creation and production spanning editorial, video, podcasts, live events, webinars, social media, sales collateral and spokesperson training.
- **120/80 CORPORATE** — Organizational consulting and communications covering issues, crises, public affairs, change, IPOs, M&A, divestitures, internal communications and CEO advisory.
- **120/80 INSIGHTS** — Market research and analytics including media and conference rankings, influencer mapping, competitive benchmarks and sector innovation indexes.
- **120/80 GROWTH** — Business marketing services for demand generation, sales enablement, patient acquisition and employee, member and patient adoption.
- **Life Sciences Innovation Index** — A study of more than 20 Fortune 500 pharmaceutical and medical-device companies, comparing AI substance - such as patents, research, investment and talent - with public prominence.
- **AGENTIC** — A conference platform announced to convene leaders at the intersection of artificial intelligence and life sciences.

## Achievements

- Built 120/80 MKTG from a 2018 launch into a multi-brand group serving digital health, healthcare AI and life sciences.
- Created AOx3 in 2024 as a second consultancy focused on the use of technology and AI in health.
- Established shared centers for studios, corporate communications, insights and growth marketing.
- Published a 2025 Life Sciences Innovation Index assessing more than 20 Fortune 500 pharmaceutical and medical-device organizations.
- Expanded senior leadership in 2024 and 2025 with appointments spanning corporate communications, life sciences and national healthcare media.

## Latest updates

- **2026-07** — The group highlighted client UpDoc's FDA clearance for software with a patient-facing large language model.
- **2026-07** — The company featured clients Withings, Twin Health, athenahealth and Color in discussions about closing healthcare's action gap.
- **2026-05** — 120/80 GROUP STUDIOS released an Incumbents & Insurgents conversation on AI in healthcare with Cleveland Clinic CEO Tomislav Mihaljevic and Aidoc co-founder Elad Walach.
- **2025-01** — At the J.P. Morgan Healthcare Conference, the company announced three senior hires, the Life Sciences Innovation Index and the AGENTIC conference concept.

## Links

- Website: https://12080group.com
- LinkedIn: https://www.linkedin.com/company/120-80-group
- Twitter/X: https://twitter.com/120over80MKTG
- Instagram: https://www.instagram.com/120over80mktg/

---

Profile page: https://yespress.io/120-80-group
Published by YesPress — https://yespress.io
Last updated: 2026-09-21
